Endonovo Therapeutics, Inc.
ENDV
$0.0002
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 32.60K | 10.90K | 100.00 | 23.10K |
| Total Receivables | -- | -- | 3.10K | -- | 900.00 |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 35.50K | 40.20K | 81.10K | 15.70K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 35.50K | 72.80K | 95.20K | 15.80K | 24.10K |
|
|
|||||
| Total Current Assets | 35.50K | 72.80K | 95.20K | 15.80K | 24.10K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 780.30K | 942.00K | 1.10M | 1.27M | 1.43M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 815.80K | 1.01M | 1.20M | 1.28M | 1.45M |
|
|
|||||
| Total Accounts Payable | 925.60K | 916.60K | 878.80K | 881.60K | 865.60K |
| Total Accrued Expenses | 9.28M | 8.76M | 8.39M | 7.99M | 7.64M |
| Short-term Debt | 104.60K | 104.60K | 109.10K | 112.10K | 116.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.95M | 6.92M | 6.79M | 7.04M | 7.12M |
| Total Finance Division Other Current Liabilities | 6.44M | 6.44M | 9.32M | 17.36M | 5.24M |
| Total Other Current Liabilities | 6.44M | 6.44M | 9.32M | 17.36M | 5.24M |
| Total Current Liabilities | 23.70M | 23.14M | 25.49M | 33.38M | 20.98M |
|
|
|||||
| Total Current Liabilities | 23.70M | 23.14M | 25.49M | 33.38M | 20.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 104.60K | 104.60K | 109.10K | 112.10K | 116.60K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 79.80K | 79.80K | 79.80K | 79.80K | 79.80K |
| Total Liabilities | 23.78M | 23.22M | 25.57M | 33.46M | 21.06M |
|
|
|||||
| Common Stock & APIC | 43.67M | 43.66M | 43.56M | 42.94M | 42.38M |
| Retained Earnings | -66.63M | -65.86M | -67.93M | -75.12M | -61.99M |
| Treasury Stock & Other | -1.60K | -1.60K | -1.60K | -1.60K | -1.60K |
| Total Common Equity | -22.96M | -22.20M | -24.37M | -32.18M | -19.61M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | -22.96M | -22.20M | -24.37M | -32.18M | -19.61M |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.96M | -22.20M | -24.37M | -32.18M | -19.61M |
|
|
|||||
